Last checked at 8 Mar 2024 07:00
Primary Health Properties PLC
Director's & PDMR dealings
On 5 March 2024, the remuneration committee of Primary Health Properties PLC (the "Company" or "PHP") made the following awards of nil-cost options under the Company's 2021 Long-term Incentive Plan ("LTIP") to a Director and Persons Discharging Managerial Responsibilities ("PDMR's").
Director | Number of shares under option |
Richard Howell | 539,779 |
PDMR | |
David Bateman | 348,137 |
Toby Newman | 115,488 |
David Austin | 131,109 |
The number of nil-cost options were calculated by reference to a price of £0.8962, being the average of the closing middle market quotations for the Company's ordinary shares on 28 February 2024, 29 February 2024 and 1 March 2024.
The nil-cost options will normally vest on the third anniversary of grant, subject to the attainment of performance conditions. The remuneration committee has the discretion to adjust the awards downwards at vesting for malus reasons. Details of the operation of the LTIP are set out in the Company's 2022 Report and Accounts.
Details of the transactions referenced above are included below in accordance with the under Article 19 of the retained EU law version of the Market Abuse Regulation (Regulation 596/2014).
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
(a) | Name | Richard Howell
| |
2 | Reason for notification | ||
(a) | Position/Status | Chief Financial Officer | |
(b) | Initial notification/amendment | Initial notification
| |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
(a) | Name
| Primary Health Properties PLC | |
(b) | LEI | 213800Y5CJHXOATK7X11
| |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted | ||
(a) | Description of the financial instrument, type of instrument and identification code | Ordinary shares of 12.5p ISIN: GB00BYRJ5J14 | |
(b) | Nature of transaction | Award of nil-cost options over the Company's ordinary shares
| |
(c) | Price(s) and volume(s) | Price(s) | Volume(s) |
Nil cost | 539,779
| ||
(d) | Aggregated Information | Single transaction: N/A
| |
(e) | Date of transaction | 7 March 2024
| |
(f) | Place of transaction | N/A
| |
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
(a) | Name | David Bateman
| |
2 | Reason for notification | ||
(a) | Position/Status | PDMR | |
(b) | Initial notification/amendment | Initial notification
| |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
(a) | Name
| Primary Health Properties PLC | |
(b) | LEI | 213800Y5CJHXOATK7X11
| |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted | ||
(a) | Description of the financial instrument, type of instrument and identification code | Ordinary shares of 12.5p ISIN: GB00BYRJ5J14 | |
(b) | Nature of transaction | Award of nil-cost options over the Company's ordinary shares
| |
(c) | Price(s) and volume(s) | Price(s) | Volume(s) |
Nil cost | 348,137
| ||
(d) | Aggregated Information | Single transaction: N/A
| |
(e) | Date of transaction | 7 March 2024
| |
(f) | Place of transaction | N/A
| |
1 | Details of the person discharging managerial responsibility/person closely associated | ||
(a) | Name | Toby Newman
| |
2 | Reason for notification | ||
(a) | Position/Status | Company Secretary & Chief Legal Officer | |
(b) | Initial notification/amendment | Initial notification
| |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
(a) | Name
| Primary Health Properties PLC | |
(b) | LEI | 213800Y5CJHXOATK7X11
| |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted | ||
(a) | Description of the financial instrument, type of instrument and identification code | Ordinary shares of 12.5p ISIN: GB00BYRJ5J14 | |
(b) | Nature of transaction | Award of nil-cost options over the Company's ordinary shares
| |
(c) | Price(s) and volume(s) | Price(s) | Volume(s) |
Nil cost | 115,488
| ||
(d) | Aggregated Information | Single transaction: N/A
| |
(e) | Date of transaction | 7 March 2024
| |
(f) | Place of transaction | N/A
| |
1 | Details of the person discharging managerial responsibilities/person closely associated | ||
(a) | Name | David Austin
| |
2 | Reason for notification | ||
(a) | Position/Status | PDMR | |
(b) | Initial notification/amendment | Initial notification
| |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||
(a) | Name
| Primary Health Properties PLC | |
(b) | LEI | 213800Y5CJHXOATK7X11
| |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date: and (iv) each place where transactions have been conducted | ||
(a) | Description of the financial instrument, type of instrument and identification code | Ordinary shares of 12.5p ISIN: GB00BYRJ5J14 | |
(b) | Nature of transaction | Award of nil-cost options over the Company's ordinary shares
| |
(c) | Price(s) and volume(s) | Price(s) | Volume(s) |
Nil cost | 131,109
| ||
(d) | Aggregated Information | Single transaction: N/A
| |
(e) | Date of transaction | 7 March 2024
| |
(f) | Place of transaction | N/A
| |
More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk
Further details:
Harry Hyman Chief Executive Officer Tel: +44 (0) 7973 344768 | Steven Owen Chairman Tel: +44 (0) 203 8241 841 |
Richard Howell Chief Financial Officer Tel: +44 (0) 7766 072272 | |
David Rydell / Stephanie Whitmore (Buchanan Communications) Tel: +44 (0) 20 7466 5066 |
Legal Entity Identifier: 213800Y5CJHXOATK7X11